Immediate Impact
50 standout
Citing Papers
Mitochondrial dysfunction in Alzheimer’s disease
2025 Standout
Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies
2025 Standout
Works of Mati Lopez‐Grancha being referenced
The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mati Lopez‐Grancha | 108 | 110 | 28 | 95 | 11 | 324 | |
| Parker Knight | 100 | 81 | 7 | 55 | 9 | 277 | |
| Emil Trofimiuk | 47 | 89 | 9 | 44 | 20 | 324 | |
| Paola Rodinò | 139 | 98 | 6 | 48 | 15 | 368 | |
| M. F. Wilkinson | 109 | 46 | 7 | 35 | 9 | 334 | |
| Kazufumi Hirano | 171 | 131 | 4 | 50 | 12 | 350 | |
| Sandra Beeské | 92 | 119 | 10 | 48 | 13 | 366 | |
| Chun Chen | 46 | 125 | 11 | 38 | 14 | 367 | |
| Miao‐Jin Ji | 70 | 100 | 11 | 30 | 13 | 345 | |
| Amy DiCamillo | 153 | 120 | 9 | 57 | 10 | 339 | |
| Elżbieta Rębas | 47 | 77 | 17 | 24 | 25 | 315 |
All Works
Loading papers...